Safety of botanical ingredients in personal care products/cosmetics

Food and Chemical Toxicology

Volumn 49, Issue 2, 2011, Pages 324-341

  Antignac, Eric ^a   Nohynek, Gerhard J ^a   Re, Thomas ^a   Clouzeau, Jacques ^a   Toutain, Hervé ^a  

^a L ORÉAL RECHERCHE   (France)

Author keywords

Botanical products; Comparative approach; Consumer safety; Personal care products; Safety assessment; Threshold of Toxicological Concern

Indexed keywords

CALENDULA EXTRACT; COSMETIC; ESSENTIAL OIL; HERBACEOUS AGENT; NATURAL PRODUCT;

BOTANY; CHEMICAL ANALYSIS; CHEMOSENSITIZATION; COMPARATIVE STUDY; DIET SUPPLEMENTATION; EXPOSURE; FOOD ALLERGY; FOOD POISONING; FOOD SAFETY; GOVERNMENT REGULATION; HERBAL MEDICINE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; PHOTOSENSITIZATION; PHYTOCHEMISTRY; PRODUCT SAFETY; REVIEW; SKIN ABSORPTION; SKIN IRRITATION; TOXICITY TESTING;

CONSUMER PRODUCT SAFETY; COSMETICS; HUMANS; PLANT PREPARATIONS; RISK ASSESSMENT; SKIN;

EID: 78951482072     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.11.022     Document Type: Review

References (198)

1. Allemann I.B., Baumann L. Botanicals in skin care products. Internat. J. Dermatol. 2009, 48:923-934.
2. Ames B.N., Profet M., Gold L.S. Dietary pesticides (99.99% natural). Proc. Natl. Acad. Sci. USA 1990, 87:7777-7781.
3. Amin S., Lahti A., Maibach H.I. Contact urticaria and the contact urticaria syndrome. Dermatotoxicology, sixth ed. 2004, 817-848. CRC Press, Boca Raton, FL, USA. H. Zhai, H.I. Maibach (Eds.).
4. Anderson B.E., Miller C.J., Adams D.R. Stinging nettle dermatitis. Am. J. Contact Dermatit. 2003, 14(1):44-46.
5. Auyeung T.W., Chang K.K., To C.H., Mak A., Szeto M.L. The patients with lead poisoning following use of a Chinese herbal pill. Hongkong Med. J. 2002, 8(1):60-62.
6. Bagchi A., Preuss H.G., Bagchi M., Stohs S.J. Phytoestrogen resveratrol and women's health. Res. Comm. Pharmacol. Toxicol. 2000, 5(1 and 2):107-121.
7. Bakkali F., Averbeck S., Averbeck D., Idaomar M. Biological effects of essential oils. Food Chem Toxicol. 2008, 46(2):446-475.
8. Barlow S.M., Greig J.B., Bridges J.W., Carere A., et al. Hazard identification by methods of animal-based toxicology. Food Chem. Toxicol. 2002, 40:145-191.
9. Basch E.M., Servoss J.C., Tedrow U.B. Safety assurances for dietary supplement policy issues and new research paradigms. J. Herbal Pharmacotherap. 2005, 5(1):3-15.
10. Basketter D., Darlenski R., Fluhr J.W. Skin irritation and sensitization: mechanisms and new approaches for risk assessment. Skin Pharmacol. Physiol. 2008, 21(3):124-135.
11. Batista, R., Oliveira, M., 2010.Plant natural variability may affect safety assessment data. Regul. Toxicol. Pharmacol. doi: 10.1016.vrtph.2010.08.019.
12. Beier R.C. Natural pesticides and bioactive compounds in food. Rev. Environ. Contam. Toxicol. 1990, 113:47-137.
13. Bent S., Ko R. Commonly used herbal medicines in the United States: a review. Am. J. Med. 2004, 116:478-485.
14. BIBRA, British Industrial Biological Research Association. Toxicity Profile of potato glycoalkaloids Issue 19, 1996. Available at: http://www.bibra-information.co.uk/toxicity_profiles_overview.html.
15. Blackburn K., Stickney J.A., Carlson-Lynch H.L., McGinnis P.M., Chappell L., Felter S. Application of the threshold of toxicological concern approach to ingredients in personal and household care products. Regul. Toxicol. Pharmacol. 2005, 43:249-259.
16. Bogusz M.J., al Tufail M., Hassan H. How natural are 'natural herbal remedies'? A Saudi perspective. Adverse Drug React. Toxicol. Rev. 2002, 21(4):219-229.
17. Bonds R.S., Midoro-Horiuti T., Goldblum R. A structural basis for food allergy the role of cross-reactivity. Curr. Opin. Allergy Clin. Immunol. 2008, 8(1):82-86.
18. Booth N.L., Overk C.R., Yao P., Burdette C.E., Nikolic D., et al. The chemical and biological profile of red clover (Trifoliatum pratense L.): phase II clinical extract. J. Altern. Compl. Med. 2006, 12(2):133-139.
19. Boyi A., Roelandts R., van den Oord J., Witte P.A. Photosensitising activity of hypericin and hypericin acetate after topical application on normal mouse skin. Brit. J. Dermaol. 2008, 158(2):360-369.
20. Breiteneder H., Radauer C. A classification of plant food allergens. J. Allergy Clin. Immunol. 2004, 113:821-830.
21. Bridges, J. 2003. Strategy for a future chemicals policy. The view of the Scientific Committee on Toxicology, Ecotoxicology and the Environment (CSTEE). Professor Jim Bridges, University of Surrey, UK. At: http://www.isopa.org/isopa/uploads/Documents/documents/White%20Paper.pdf.
22. Chan T.Y., Critchley J.A. Usage and adverse effects of Chinese herbal medicines. Hum. Exp. Toxicol. 1996, 15(1):5-12.
23. Chan T.Y. Potential dangers from topical preparations containing methylsalicylate. Hum. Exp. Toxicol. 1996, 15(9):747-750.
24. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 2003, 52:1361-1371.
25. Cheeseman M.A., Machuga E.J., Bailey A.B. A tiered approach to threshold of regulation. Food Chem. Toxicol. 1999, 37:387-412.
26. Chuang C.H., Doyle P., Wang J.D., Chang P.J., Lai J.N., Chen P.C. Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study. Drug Saf. 2006, 29(6):537-548.
27. CIR US cosmetic ingredient review. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, and benzylparaben as used in cosmetic products. Int. J. Toxicol. 2008, 27(suppl. 4):1-82.
28. CIR, US cosmetic ingredient Review, 2010. A list of ingredients reviewed by the CIR is available at: http://www.cir-safety.org/i.
29. Codex Alimentarius, 1997. Recommended International Code of Practice-General Principles of Food Hygiene including Annex on Hazard Analysis and Critical Control Point (HACCP) System and Guidelines for its Application. At: http://www.freshquality.org/files/Hygiene.pdf.
30. Coderanu F., Morisset M., Cordebar V., Kanny G., Moneret-Vautrin D.A. Risk of allergy to food proteins in topical medicinal agents and cosmetics. Eur. Ann. Allergy Clin. Immunol. 2006, 38(4):126-130.
31. Cohen P.A. American roulette - contaminated dietary supplements. N. Engl. J. Med. 2009, 361(16):1423-1525.
32. Constable A., Jonas D., Cockburn A., Davi A., Edwards G., et al. History of safe use as applied to the safety assessment of novel foods and foods derived from genetically modified organisms. Food Chem. Toxicol. 2007, 45:2513-2525.
33. Coppens P., Delmulle L., Gulati O., Richardson D., Ruthsatz M., Sievers H., Sidani S. Use of botanicals in food supplements: regulatory scope, scientific risk assessment and claim substantiation. Ann. Nutr. Metabol. 2006, 50(6):538-554.
34. Corbett, J.E., Sharma, R.K., Dressler, W.E., 1999. Cosmetic toxicology. In: Marquardt, H., Schäfer, S.G., McClellan, R.O., Welsch, F. (Eds.), Toxicology. Academic Press, San Diego, CA, USA, pp. 899-918 (Chapter 30).
35. Cosyns J.P. Aristolochic acid and «Chinese herbs nephropathy»: a review to the evidence to date. Drug Saf. 2003, 26(1):33-48.
36. Cramer G.M., Ford R.A., Hall R.L. Estimation of toxic hazard - decision tree approach. Food Cosm. Toxicol. 1978, 16(3):255-276.
37. Deng J.F., Lin T.J., Kao W.F. The difficulty in handling poisonings associated with Chinese traditional medicine: a poison control center experience for 1991-1993. Vet. Hum. Toxicol. 1997, 39(2):106-114.
38. Devos S.A., Constandt L., Tupker R.A., Noz K.C., et al. Relevance of positive patch-test reactions to fragrance mix. Dermatitis 2008, 19(1):43-47.
39. Dharmananda, S. 2010. Safety issues affecting Chinese herbs: the case of Dictamnus and herbs for skin diseases. Article published by the Institute for Traditional Medicine. Portland, Oregon, USA. Available at: http://www.itmonline.org/arts/dictamnus.htm.
40. Dickens P., Tai Y.T., But P.P.H., Tomlinson B., Ng H.K., Yan K.W. Fatal accidental aconitine poisoning following ingestion of Chinese herbal medicine: a report of two cases. Forens. Sci. Intern. 1994, 67:55-58.
41. Drasar P., Moravcova J. Recent advances in analysis of Chinese medical plants and traditional medicines. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2004, 812(1-2):3.21.
42. ECB (European Chemical Bureau), 2003. Technical guidance document (TGD) on risk assessment in support of Commission Directive 93/67/EEC on risk assessment for new notified substances. European Commission, Part 1, 1-303. At: http://www.ecb.jrc.ec.europa.eu/documents/TECHNICAL_GUIDANCE_DOCUMENT/EDITION_2/tgdpart2_2ed.pdf.
43. EC, 1976. Council Directive 76/768/EEC of July 27, 1976 on the Approximation of the Laws of the Member States Relating to Cosmetic Products. At: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31976L0768:en:HTML.
44. EC (1997). Regulation (EC) No. 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients. Official Journal of the European Communities, L 43/1-7, 14 February 1997.
45. EC Regulation Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the European Communities L 311/67 of the 28.11.2001.
46. EC Regulation Directive No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. Official Journal of the European Communities L 31/1 of the 1.2.2002.
47. EC Regulation Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union L 136/85 of the 30.4.2004.
48. EC, 2004. Guidance Document on Dermal Absorption. European Commission, Health and Consumer protection Directorate General, Directorate E, Food safety, plant health, animal health and welfare, 19 March, 2004. At: http://ec.europa.eu/food/plant/protection/evaluation/guidance/wrkdoc20_rev_en.pdf.
49. Edwards G. Safety assessment of novel foods and strategies to determine their safety in use. Toxicol. Appl. Pharmacol. 2005, 207:623-627.
50. EFSA, (2004). Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food, 2004. Opinion on Flavouring Group FGE.03 Acetals of branched- and straight-chain aliphatic saturated primary alcohols and branched- and straight-chain saturated aldehydes, and an orthoester of formic acid, from chemical groups 1 and 2. Opinion expressed on 7 October 2004. At: http://www.efsa.europa.eu/en/ceftopics/topic/flavourings.htm.
51. EFSA, GMO Panel Working Group on Animal Feeding Trials Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. Food. Chem. Toxicol. 2008, 46(Suppl. 1):2-70.
52. EFSA Scientific Committee. 2009. Guidance on safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements. EFSA J. 7 (9), 1249, 1-18.
53. EFSA Scientific opinion on lead in food. EFSA Panel on Contaminants in the Food Chain (CONTAM). EFSA J. 2010, 980:1-139.
54. EPA, 2006. US Environmental Protection Agency. Proposed Test Rule for In Vitro Dermal Absorption Rate Testing of Certain Chemicals of Interest to Occupational Safety and Health Administration. At: http://www.federalregister.gov/articles/2006/08/02/E6-12340/tsca-chemical-testing-receipt-of-test-data.
55. Ernst E. Harmless herbs? A review of the recent literature. Am. J. Med. 1998, 104:170-178.
56. Ernst E. Adverse effects of herbal drugs in dermatology. Br. J. Dermatol. 2000, 143(5):923-929.
57. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann. Intern. Med. 2002, 136:42-53.
58. Ernst E. Risks of herbal medicinal products. Pharmacoepidemiol. Drug Safety 2004, 13(11):767-771.
59. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharm. Sci. 2002, 23(3):136-139.
60. ESCO EFSA Scientific Cooperation (ESCO) Report. EFSA Compendium of botanicals that have been reported to contain toxic, addictive, psychotropic or other substances of concern. EFSA J. 2009, 7(9):281.
61. Essers A.J.A., Alink G.M., Speijers G.J.A., Alexander J., et al. Food plant toxicants and safety. Risk assessment and regulation of inherent toxicants in plant foods. Environ. Toxicol. Pharmacol. 1998, 5:155-172.
62. European Medicines Agency (EMEA), 2003. The European Medical Control Agency. Committee for Medicinal Products for Human Use. Guideline on the Limits of Genotoxic Impurities, London, 23 June 2003. At: http://www.ema.europa.eu.
63. European Medicines Agency (EMEA), 2004. European Medicines Evaluation Agency. Committee for Medicinal Products for Human Use (CHMP). Guideline on the Limits of Genotoxic Impurities. CPMP/SWP/5199/02, London, 23 June 2004. At: http://www.ema.europa.eu.
64. European Medicines Agency (EMEA). Committee on herbal medicinal products, 2005. Public Statement on the Risks Associated with the Use of Herbal Products Containing Aristolochia Species. EMEA/HMPC/138381/2005. At: http://www.ema.europa.eu.
65. European Medicines Agency (EMEA). Committee on herbal medicinal products, 2006a. Guideline on Non-clinical Documentation for Herbal Medicinal Products in Application for Marketing Authorisation (Bibliographical and Mixed Applications) and in Applications for Simplified Registration. EMEA/HMPC/32116/2005. At: http://www.ema.europa.eu.
66. European Medicines Agency (EMEA), 2006b. Guideline on Good Agricultural and Collection Practice (GACP) for Starting Materials of Herbal Origin. EMEA/HMPC/246816/2005. At: http://www.ema.europa.eu.
67. European Medicines Agency (EMEA), 2006c. Guideline on Specifications: Test Procedures and Acceptance Criteria for Herbal Substances, Herbal Preparations and Herbal Medicinal Products/Traditional Herbal Medicinal Products. CPMP/QWP/2820/00 Rev 1 and EMEA/CVMP/815/00 Rev 1. At: http://www.ema.europa.eu.
68. European Medicines Agency (EMEA), 2008a. Reflection Paper on Markers used for Quantitative and Qualitative Analysis of Herbal Products and Traditional Herbal Medicinal Products. EMEA/HMPC/253629/2007. At: http://www.ema.europa.eu.
69. European Medicines Agency (EMEA). Committee on Herbal Medicinal Products, 2008b. Draft assessment report on Hypericum perforatum L., herba. EMEA/HMPC/101303/2008 Corr. At: http://www.ema.europa.eu.
70. European Medicines Agency (EMEA), 2009. Committee on Herbal Medicinal Products (HMPC): Overview of HMPC assessment work - status September 2009. EMEA/HMPC/278067/2006. At: http://www.ema.europa.eu.
71. European Scientific Cooperative on Phytotherapy (ESCOP) Monographs, 2003. Second ed. Available at: http://www.escop.com.
72. EU (2006). Regulation (EC) 1907/2006 of the European Parliament and the European Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Regulation 1999/45/EC and repealing Council Regulation (EEC) No 93/793 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/677/EEC, 93/105/EEC and 2000/21/EC. Off. J. Eur. Comm. L 369, 30 December 2006, 849.
73. FDA, US Food and Drug Administration, 1997. FDA regulation of performance-enhancing supplements - a proposal to reform the dietary supplement health and education act of 1994. At: http://leda.law.harvard.edu/leda/data/171/egarcia.pdf.
74. FDA, US Food and Drug Administration Food additives; threshold of regulation for substances used in food-contact articles. Fed. Regist. 1993, 58(195):52719-52727.
75. FDA, US Food and Drug Administration, 2003. Proposal for Dietary Supplements. Current Good Manufacturing Practices (CGMPs). At: http://www.fda.gov/Food/DietarySupplements/GuidanceComplianceRegulatoryInformation/RegulationsLaws/ucm110863.htm.
76. FDA, US Food and Drug Administration.21 CFR Part 119.February 11 Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule. Fed. Regist. 2004, 69(28):6787-6854.
77. FDA, US Food and Drug Administration, 2004b. Guidance for industry - botanical drug products. Center for Drug Evaluation and Research (CDER). At: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070491.pdf.
78. Federal Register, 2007. US Food and Drug Administration, Petition to request an exemption from 100 percent identity testing of dietary ingredients: current good manufacturing practices in manufacturing, packaging, labelling or holding operations for dietary supplements. Fed. Reg. Final Rule and Interim final rule. June 25, 2007. At: http://www.fda.gov/Food/DietarySupplements/GuidanceComplianceRegulatoryInformation/RegulationsLaws/ucm079573.htm.
79. FSANZ, 1999. Standard 1.5.1 (Novel Foods) of the Food Standards Code, Food Standards Australia New Zealand. Available at: http://www.foodstandards.gov.au/.
80. Fu P.P., Chiang H.M., Xia Q., Chen T., Chen B.H., Yin J.J., Wen K.C., Lin G., Lin G., Yu H. Quality assurance and safety of herbal dietary supplements. J. Environ. Sci. Health, part C 2009, 27:91-119.
81. Fu H.Y., Chen S.J., Chen R.F., Ding W.H., et al. Identification of oxalic and tartaric acid as major persistent pain-inducing toxins in the stinging hair of the nettle, Urtical thunbergiana. Ann. Bot. 2006, 98(1):57-65.
82. Gold L.S., Sawyer C.B., Magaw R., Backman G.M., de Veciana M., Levinson R., Hooper N.K., Havender W.R., Bernstein L., Peto R., Pike M., Ames B.N. A carcinogenesis potency database of the standardized results of animal bioassays. Environ. Health Persp. 1984, 58:9-319.
83. Gomase V.S., Changbhale S.S., Patil S.A., Kale K.V. Metabolomics. Curr. Drug Metab. 2008, 9:89-98.
84. Greim H. Chemicals with endocrine-disrupting potential: a threat to human health?. Angew. Chem. Int. Ed. 2005, 44:5568-5574.
85. Grievson M., Barber J., Hunting A.L.L. Natural ingredients in cosmetics 1993, Micelle Press, Cranford, N.J., USA.
86. Grimshaw B. Natural and nature-identical fragrances - a new creative challenge. Natural Ingredients in Cosmetics 1993, 7-19. Micelle Press, Cranford, N.J., USA. M. Grievson, J. Barber, A.L.L. Hunting (Eds.).
87. Hagemann U. Nutzen-schaden-bewertung von pflanzlichen arzneimitteln: das beispiel Kava-kava. Bundesgesundheitsbl. Gesundheitsforsch. Gesundheitsschutz 2003, 46:1068-1073.
88. Haimanot R.T., Kidane Y., Wuhib E., Kalissa A., et al. Lathyrism in rural northwestern Ethiopia: a highly prevalent neurotoxic disorder. Int. J. Epidemiol. 1990, 19(3):664-672.
89. Harrigan, G.G., Glenn, K.C., Ridley, W.P., 2010. Assessing the natural variability in crop composition. Regul. Toxicol. Pharmacol. doi: 10.1016/j.yrtph.2010.08.23.
90. Health Canada, 2003. Amendment (Schedule No. 948) to Division 28 of the Food and Drug Regulations, Sections B.28.001-003.At: http://www.hc-sc.gc.ca/fn-an/gmf-agm/pol/index-eng.php.
91. Health Canada, 2006. Guidelines for the safety assessment of novel foods. At: http://www.hc-sc.gc.ca/fn-an/gmf-agm/pol/index-eng.php.
92. ILSI, (2003). The safety assessment of novel foods and concepts to determine their safety in use. ILSI Europe Report Series. At: http://www.ilsi.org/Europe/Publications/Forms/AllItems.aspx.
93. ICH, 2009. International Conference on Harmonisation. ICH Topic Q3C, Impurities: Guideline for Residual Solvents. Update February 2009. Available at: http://www.ema.emea.europa.eu.
94. ICH, 2010. International Conference on Harmonisation. ICH Topic Q3D, Residues of heavy metals in drug products: lead, arsenic, mercury and cadmium. Draft guidelines to be discussed at the forthcoming ICH meeting in Fukuoka, Japan, Nov. 8-11, 2010. Will be made available at: http://www.ema.emea.europa.eu.
95. IPCS, 1998. Toxicological evaluation of certain food additives and contaminants in food. International Program on Chemical Safety, World Health Organisation, WHO Food Additives Series 35, WHO, Geneva, Switzerland.
96. IPGRI (International Plant Genetic Resources Institute), 2004. Conserving and Increasing the Use of Neglected and Underutilized Crop Species At: http://mcknight.ccrp.cornell.edu/projects/neglected.html.
97. Jonas D.A., Antignac E., Antoine J.M., Classen H.G., Huggett A., Knudsen, et al. The safety assessment of novel foods. Food Chem. Toxicol. 1996, 34:931-940.
98. Jones, A.D., Dick, J.P., Cherrie, J.W., Cronin, M.T.D., Van de Sandt, J.J.M. et al. 2004. CEFIC workshop on methods to determine dermal permeation for human risk assessment. Research Report TM/04/07, December 2004.
99. JECFA Evaluation of Certain Food Additives and Contaminants. Safety evaluation of flavouring agents. In: Forty-first Report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 837 1993, World Health Organization, Geneva, Switzerland.
100. JECFA, 1995. Evaluation of Certain Food Additives and Contaminants. Safety evaluation of flavouring agents. In: Forty-fourth Report of the Joint FAO/WHO Expert Committee on Food Additives, WHO Technical Report Series 859, 2-3, World Health Organization, Geneva, Switzerland.
101. JECFA (1998). Safety evaluation of certain food additives and contaminants. In: 49th Meeting of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization (WHO), International Programme on Chemical Safety (IPCS), WHO Food Additives Series, No. 40. World Health Organization, Geneva, Switzerland.
102. JECFA, 1999. Evaluation of Certain Food Additives and Contaminants. Procedure for the safety evaluation of flavouring agents. In: Fortyninth Report of the Joint FAO/WHO Expert Committee on Food Additives, WHO Technical Report Series 884, 3-6. World Health Organization, Geneva, Switzerland.
103. JECFA, 2003. Summary of Evaluations Performed by the Joint FAO/WHO Expert Committee on Food Additives (JECFA 1956-2003). In: First through sixty-first meetings. World Health Organization, Geneva, Switzerland.
104. Jordan S.A., Cunnigham D.G., Marles R.J. Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol. Appl. Pharmacol. 2010, 243:198-216.
105. Kelling C.K., Bartolo R.G., Ertel K.D., Smith L.A., et al. Safety assessment of enzyme-containing personal cleansing products: exposure characterization and development of IgE antibody to enzymes after a 6-month use test. J. Allergy Clin. Immunol. 1998, 101:179-187.
106. Killig C., Werfel T. Contact reactions to food. Curr. Allergy Asthma Rep. 2008, 8(3):209-214.
107. Kleinmann M.H., Smith M.D., Kurali E., Kleinpeter S., et al. An evaluation of chemical photoreactivity and the relation to phototoxicity. Regul. Toxicol. Pharmacol. 2010, 58(2):224-232.
108. Kluger N., Raison-Peyron N., Guillot B. Temporary henna tattoos: sometimes serious side effects. Presse Med. 2008, 37(7-8):1138-1142.
109. Knudsen I., Søborg I., Eriksen F., Pilegaard K., Pedersen J. Risk management and risk assessment of novel plant foods: concepts and principles. Food Chem. Toxicol. 2008, 46:1681-1705.
110. Ko R.J. Adulterants in Asian patent medicines. N. Engl. J. Med. 1998, 339(12):839-841.
111. König A., Cockburn A., Crevel R.W.R., Debruyne E., et al. Asessment of the safety of foods derived from genetically modified (GM) crops. Food Chem. Toxicol. 2004, 42:1047-1088.
112. Kroes R., Galli C.L., Munro I., Schilter B., Tran L.-A., Walker R., Würtzen G. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. Food Chem. Toxicol. 2000, 38:255-312.
113. Kroes R., Walker R. Safety issues of botanicals and botanical preparations in functional foods. Toxicology 2004, 198:213-220.
114. Kroes R., Renwick A.G., Cheeseman M., Kleiner J., Mangelsdorf I., et al. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem. Toxicol. 2004, 42:65-83.
115. Kroes R., Renwick A.G., Feron V., Galli C.L., Gibney M., Greim H., Guy R.H., Lhuguenot J.C., van de Sandt J.J. Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients. Food Chem. Toxicol. 2007, 45(12):2533-2562.
116. Lademann J., Richter H., Jacobi U., Patzelt A., Hueber-Becker, et al. Human percutaneous absorption of a direct hair dye comparing in vitro and in vivo results: implications for safety assessment and animal testing. Food Chem. Toxicol. 2008, 46:2214-2223.
117. Lalko J., Api A.M. Investigation of the dermal sensitization potential of various essential oils in the local lymph node assay. Food Chem. Toxicol. 2006, 44:739-746.
118. Lee T.Y., Lam T.H. Irritant contact dermatitis due to a Chinese herbal medicine lu-shen-wan. Contact Dermatit. 1988, 18(4):213-218.
119. Lee T.Y., Lam T.H. Patch testing of 11 common herbal topical medicaments in Hong Kong. Contact Dermatit. 1990, 22(3):137-140.
120. Lehman-McKeenan L.D. Absorption, distribution and excretion of toxicants. Casarett and Doull's Toxicology - The Basic Science of Poisons, seventh ed. 2008, 131-159. McGraw Hill, New York, USA., (Chapter 5). C.D. Klaassen (Ed.).
121. Levin C., Warshaw E. Protein contact dermatitis: allergens, pathogens and management. Dermatitis 2008, 19(5):241-251.
122. Lim Y.L., Thirumoorthy T. Serious cutaneous reactions to traditional Chinese medicines. Singapore Med. J. 2005, 46(12):714-717.
123. Liu Z.J., Zhang B.H., Hu X. Traditional Chinese medicines such as heche dazao capsules should not be prescribed for patients with sex-hormone-dependent tumors. Clin. Pharmacol. Therap. 2010, 88(3). Epub 2010, July 28, 2010.
124. Local Harvest, 2010. At: http://www.localharvest.org/red-clover-tea-C8814.
125. Lundov M.D., Moesby L., Zachariae C., Johansen J.D. Conservation versus preservation of cosmetics: a review of legislation, usage, infections and contact allergy. Contact Dermatit. 2008, 60(2):70-78.
126. Mantle D., Gok M.A., Lennard T.W. Adverse and beneficial effects of plant extracts on skin or skin disorders. Adverse Drug React. Toxicol. Rev. 2001, 20(2):89-103.
127. McKee L.H. Microbial contamination of spices and herbs. Food. Sci. Technol. 1995, 28(1):1-11.
128. McNamara S.H. Dietary supplements of botanicals and other substances: a new era of regulation. Food Drug Law J. 1995, 50(3):341-348.
129. Micozzi M.S., Pribitkin E.A. Common herbal remedies, adverse reactions and dermatological effects. Skin Med. 2010, 8(1):30-36.
130. Mikic, A., Mihailovic, V., Cupina, B., Duric, B., et al., 2010.Towards the re-introduction of grass pea (Lathyrus sativus) in the West-Balkan countries: the case of Serbia and Srpska (Bosnia and Herzegovina). Food Chem. Toxicol. doi: 10.1016/j.fct.2010.07.052.
131. Mlingi N., Poulter N.H., Posling H. An outbreak of acute intoxication from consumption of insufficiently processed cassava in Tanzania. Nutr. Res. 1992, 12:677-678.
132. Modi G.M., Doherty C.B., Katta R., Orengo I.F. Irritant dermatitis from plants. Dermatitis 2009, 20(2):63-78.
133. Müller L., Mauthe R.J., Riley C.M., Andino M.M., et al. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Reg. Toxicol. Pharmacol. 2006, 44:198-211.
134. Munro I.C. Safety assessment procedures for indirect food additives: an overview. Regul. Toxicol. Pharmacol. 1990, 12:2-12.
135. Munro I.C., Ford R.A., Kennepohl E., Sprenger J.G. Correlation of structural class with no-observed-effect levels: a proposal for establishing a threshold of concern. Food Chem Toxicol. 1996, 34(9):829-867.
136. Munro I.C., Kennepohl E. Comparison of estimated daily per capita intakes of flavouring substances with no-observed-effect levels from animal studies. Food Chem. Toxicol. 2001, 39:331-354.
137. Munro I.C., Danielewska-Nikiel B. Comparison of estimated daily intakes of flavouring substances with no-observed-effect levels. Food Chem. Toxicol. 2006, 44:758-809.
138. Munro I.C., Renwick A.G., Danielewska-Nikiela B. The Threshold of Toxicological Concern (TTC) in risk assessment. Toxicol. Lett. 2008, 180:151-156.
139. Navarro V.J. Herbal and dietary supplement hepatotoxicity. Seminar Liv. Dis. 2009, 29(4):373-382.
140. NETTOX, 1998. Nettox List of Food Plants. Information on inherent food plant toxicants, Report 2. Danish Vet. Food Adm., Søborg, Denmark.
141. Nohynek G.J., Antignac E., Re T., Toutain H. Safety assessment of personal care products/cosmetics and their ingredients. Toxicol. Appl. Pharmacol. 2010, 243(2):378-393.
142. Nortier J.L., Muniz Martinez M.-C., Schmeiser H.H., Arlt V.M., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fanghi). N. Engl. J. Med. 2000, 342(23):1686-1692.
143. Norton, S. 2008. Toxic effects of plants. In: C.D. Klassen (Ed.), Casarett and Doull's Toxicology, The Basic Science of Poisons, seventh ed. McGraw Hill, New York, 2008. pp. 1103-1115.
144. NTP, National Toxicology Program, 2003. Fact Sheet, Herbal Medicines. National Toxicology Program, 2008. Aristolochic Acids. Reports on Carcinogens. Available at: http://ntp.niehs.nih.gov/ntp/htdocs/Liason/factsheets/HerbMedFacts.pdf.
145. OECD Organisation for Economic Co-operation and Development, Paris, France. OECD Guidelines for the testing of chemicals, Guideline 428, Skin Absorption: In Vitro Method, 13 April, 2004 2004, OECD, Paris, France.
146. OECD Organisation for Economic Co-operation and Development. Paris, France. OECD Environmental Health and Safety Publications, Series on Testing and Assessment No. 28, Guidance Document for the conduct of Skin Absorption Studies, 5 March, 2004 2004, OECD, Paris, France.
147. OECD Guidance on Grouping of Chemicals (n 80). ENV/JM/MONO(2007)28 2007, OECD, Paris, France.
148. Okeke I.N., Lamikanra A. Bacteriological quality of skin-moisturizing creams and lotions distributed in a tropical developing country. J. Appl. Microbiol. 2008, 91(5):922-928.
149. Organic Monitor, 2007. The North American Market for Natural & Organic Personal Care Products. Report: 3001-60 Posted: September 17th 2007. At: http://www.marketresearch.com/vendors/viewvendor.asp?g=1&vendorid=2701.
150. Patisaul, H.B., Jefferson, W., 2010. The pros and cons of phytoestrogens. Front. Neuroendocrinol. doi: 10.1016/j.frne.2010.03.003.
151. Petroczi, A., Taylor, G., Naughton, D.P. 2010. Mission impossible? Regulatory and enforcement issues to ensure safety of dietary supplements. Food Chem. Toxicol. doi: 10.1016/j.fct.2010.11.04.
152. Re T.A., Mooney D., Antignac E., Dufour E., Bark I., Srinivasan V., Nohynek G. Application of the threshold of toxicological concern approach for the safety evaluation of calendula flower (Calendula officinalis) petals and extracts used in cosmetic and personal care products. Food Chem. Toxicol. 2009, 47:1246-1254.
153. Reider N., Komericki P., Hausen B.M., Fritsch P., Aberer W. The seamy side of natural medicines: contact sensitization to arnica (Arnica Montana) and marigold (Calendula officinalis L.). Contact Dermatit. 2001, 45(5):269-272.
154. Renwick A.G. Toxicology databases and the concept of thresholds of toxicological concern as used by the JECFA for the safety evaluation of flavouring agents. Toxicol. Lett. 2004, 149:223-234.
155. Reuter J., Merfort I., Schempp C.M. Botanicals in dermatology: en evidence-based review. Am. J. Clin. Dermatol. 2010, 11(4):247-267.
156. Rodriguez-Fragoso L., Reyes-Esparza J., Burchiel S.W., Herrera-Ruiz D., Torres E. Risks and benefits of commonly used herbal medicines in Mexico. Toxicol. Appl. Pharmacol. 2008, 227:125-135.
157. Rossato, L.G., Costa, V.M., Limberger, R.P., Bastos, M.D.L., Remiao, F. 2010. Synephrine: from trace concentrations to massive consumption in weight loss. Food. Chem. Toxicol. doi: 10.1016/j.fct.2010.11.007.
158. Rousseaux C.G., Schachter H. Regulatory issues concerning the safety, efficacy and quality of herbal remedies. Birth Defects Res. (Part B) 2003, 68:505-510.
159. Rutherford T., Nixon R., Tam M., Tate B. Allergy to tea tree oil: retrospective review of 41 cases with positive patch tests over 4.5 years. Australas J. Dermatol. 2007, 48(2):3-87.
160. Safe S. Endocrine disruptors and human health: is there a problem?. Toxicology 2004, 205:3-10.
161. Safford R.J. The dermal sensitisation threshold - a TTC approach for allergic contact dermatitis. Regul. Toxicol. Pharmacol. 2008, 51:195-200.
162. Sartorelli P., Andersen H.R., Angerer J., Corish, et al. Percutaneous penetration studies for risk assessment. Environ. Toxicol. Pharmacol. 2000, 8:133-152.
163. Sasseville D. Phytodermatitis. J. Cutan. Med. Surg. 1999, 3(5):263-279.
164. SCCP, 2006a. The SCCP's Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation. 6th Revision. 19 December 2006. At: http://www.ec.europa.eu.
165. SCCP, 2006b. Scientific Committee on Consumer Products. Basic Criteria for the In Vitro Assessment of Dermal Absorption of Cosmetic Ingredients - Updated March 2006, Adopted 28th March, 2006. At: http://www.ec.europa.eu/health/ph_risk/committees.
166. SCCS, 2010. Scientific Committee on Consumer Safety. Basic Criteria for the In Vitro Assessment of Dermal Absorption of Cosmetic Ingredients - Updated June 2010, Adopted 22nd June 2010. At: http://ec.europa.eu/health/scientific_committees/consumer_safety/index_en.htm.
167. SCF, Scientific Committee for Food (1997). Opinion on The Assessment of Novel Foods: Food Science and Techniques: Reports of The Scientific Committee for Food (fortieth series). Directorate-General Industry, European Commission. At: http://www.ec.europa.eu/health/ph_risk/committees/.
168. Schulz V. Safety of St. John's wort extract compared to synthetic antidepressants. Phytomedicine 2006, 13(3):199-204.
169. SCP, 2002. Scientific Committee on Plants. Opinion on the draft guidance on dermal absorption, European Commission, Health and Consumer Protection Directorate General, Directorate C - Scientific Opinions C2 - Management of scientific committees, scientific co-operation and networks, 30 April, 2002. At: http://www.ec.europa.eu/health/ph_risk/committees.
170. Schmeiser H.H., Stiborova M., Arlt V.M. Chemical and molecular basis of the carcinogenicity of Aristolochia plants. Curr. Opin. Drug Discov. Develop. 2009, 12(1):141-148.
171. Schempp C.M., Schöpf E., Simon J.C. Plant-induced toxic and allergic dermatitis (pohytodermatitis). Hautarzt 2002, 53(2):93-97.
172. Schilter B., Andersson C., Anton R., Constable A., Kleiner J., et al. Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem. Toxicol. 2003, 41:1625-1649.
173. Schmidt J. Phytophotodermatitis. Dermatol. Nurs. 2007, 19(5):486-498.
174. Shelton R.C., Keller M.B., Gelenberg A., Dunner D.L., et al. Effectiveness of St. John's wort in major depression: a randomized, controlled trial. JAMA 2001, 285(15):1976-1986.
175. Smith R.L., Adams T.B., Cohen S.M., Doull J., et al. Safety evaluation of natural flavour complexes. Toxicol. Lett. 2004, 149(1-3):197-207.
176. The American Botanical Council, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Editor Mark Blumenthal. Reviewed at: http://www.cms.herbalgram.org/press/nejmletter.html.
177. Tindle H.A., Davis R.B., Phillips R.S., Eisenberg D.M. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern. Therap. 2005, 11(1):42-49.
178. Traynor N.J., Beattie P.E., Ibbotson S.H., Moseley H., Ferguson J., Woods J.A. Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's wort supplements and high dose UVA-1 therapy. Toxicol. Lett. 2005, 158:220-224.
179. USDA. US Department of Agriculture, 2010. Natural Resources Conservation Service. Culturally significant plants. At: http://plants.usda.gov/java/factSheet?cultural=yes.
180. US Dietary Supplement Health and Education Act, 1994, US Government Printing Office, Washington DC 20402. Reviewed at: http://www.worldfoodscience.org/cms/?pid=1004323.
181. US FDA, 1995. US Food and Drug Administration. Food Additives: Threshold of Regulation for Substances Used in Food-Contact Articles. Final Rule. Federal Register 60, 36582-36596, Monday July 17, 1995.
182. Van Ravenzwaay, B., Damman, M., Buesen, R., Schneider, S. 2010. The threshold of toxicological concern for prenatal developmental toxicity. Regul. Toxicol. Pharmacol. doi: 10.1016/j.rtph.2010.09.009.
183. Vovolis V., Kalogiros L., Ivanova D., Koutsostathis N. Garlic-induced severe anaphylaxis in a nonatopic patient. J. Investig. Allergol. Clin. Immunol. 2010, 20(4):356.
184. Walji R., Boon H., Barnes J., Austin Z., Welsh S., Baker G.R. Consumers of natural health products: natural-born pharmacovigilantes?. BMC Complim. Altern. Med. 2010, 10(8):1-10.
185. What's the harm? (2010). At: http://whatstheharm.net/herbalremedies.html.
186. WHO, 1987. Principles for the safety assessment of food additives and contaminants in food. Tech. Rep. Series 70. WHO, Geneva, Switzerland.
187. WHO, 1995. Application of the principles of substantial equivalence to the safety evaluation of foods or food components from plants derived by modern biotechnology. In: Report of a WHO Workshop. World Health Organisation, Geneva, Switzerland. At: http://www.apps.who.int/fsf/whopb2.htm.
188. WHO, 2003. Guidelines on good agricultural and collection practices (GACP) for medicinal plants. World Health Organisation, Geneva, Switzerland. At: http://www.whqlibdoc.who.int/publications/2003/9241546271.pdf.
189. Willett K.L., Roth R.A., Walker L. Workshop overview: hepatotoxicity assessment for botanical dietary supplements. Toxicol. Sci. 2004, 79(Suppl. 3):4-9.
190. Wolf de W., Sieber-Sauer A., Lecloux A., Koch A., Holt M., Feytel T., Comber M., Boeije G. Mode of action and aquatic exposure thresholds of no concern. Environ. Tox. Chem. 2005, 24:479-485.
191. Woolf A.D., Watson W.A., Smolinske S., Litovitz T. The severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993-2002. Clin. Toxicol. 2005, 43(5):347-355.
192. Wu K.M., DeGeorge J., Atrakchi A., Barry E., et al. A special update from the United States Food and Drug Administration: preclinical issues and status of investigation of botanical drug products in the United States. Toxicol. Lett. 2000, 111:199-202.
193. Wu K.M., Ghantous H., Birnkrant D.B. Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States. Food Chem. Toxicol. 2008, 46:2606-2610.
194. Wüthrich B. Food-induced cutaneous adverse reactions. Allergy 1998, 53(Suppl. 46):131-135.
195. Yan Z.Y., Spencer P.S., Li Z.X., Liang Y.M., Wang Y.F., Wang C.Y., Li F.M. Lathyrus sativus (grass pea) and its neurotoxin ODAP. Phytochemistry 2006, 67:107-121.
196. Yu H., Zhong S., Chan K., Berry M. Pharmacognostical investigations on traditional Chinese medicinal herbs: identification of four herbs from the UK market. J. Pharm. Pharmacol. 1995, 47:1129-1137.
197. Zhai H., Ebel J.P., Chatteriee R., Stone K.J., et al. Hydration vs. skin permeability to nicotinates in man. Skin Res. Technol. 2002, 8(1):13-18.
198. Zuidmeer L., Goldhahn K., Rona R.J., Gislason D., et al. The prevalence of plant food allergies: a systematic review. J. Allergy Clin. Immunol. 2008, 121:1210-1218.